MRI-Guided Radiation for Limited Abdominal Cancer Spread
Part of Cancer, Digestive system clinical trials.
This trial tests a new type of radiation therapy guided by MRI scans to treat small areas of cancer that have spread to the lining of your abdomen. It may offer better targeting and fewer side effects than standard radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have 5 or fewer spots of cancer visible on MRI scans in your abdominal cavity
- You have had prior surgery to remove abdominal cancer (with or without heated chemotherapy) in the past
- You have not had radiation therapy to your abdomen within the last 6 months
- You are healthy enough to tolerate treatment (your doctor will assess this)
- You can commit to follow-up visits and comply with the study schedule
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of highly focused radiation (ablative radiosurgery versus stereotactic radiation in 5 sessions) for people with a small number of metastases in the bone. It aims to find which approach controls these spots with fewer side effects while keeping the treatment “radical,” meaning trying to wipe out the targeted lesions.
This trial tests whether high-precision radiation (SBRT) can improve outcomes for people with up to 5 small, stable metastases from certain cancers, compared to usual palliative care. It is for those whose disease is not growing after current chemotherapy.
This trial tests if MRI-guided radiation can precisely target and treat cancer that has spread to a few spots in the abdomen (like the liver or lymph nodes). It's for people whose original cancer is under control and who have up to 5 small tumors in up to 2 body areas.
This feasibility study tests whether MRI-guided, highly focused radiation can be safely delivered to tumors in the abdomen or central lung. It may help patients with a small number of metastases by aiming treatment more precisely and gathering detailed outcomes for future care.
This trial studies whether stereotactic (high-precision) radiation given in a few sessions can control rare cancers that have spread to a small number of sites. It aims to help by treating all known spots while keeping side effects manageable.
This trial tests a single, high-dose radiation treatment (SBRT) guided by MRI for people with colorectal cancer that has spread to the liver. The goal is to see if this precise, one-time treatment can effectively control liver tumors while protecting nearby organs.
Hear when a new Peritoneal Carcinomatosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.